Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages

Scandinavian Journal of Immunology

Volumn 51, Issue 3, 2000, Pages 244-250

  Halaas, O ^a   Vik, R ^a   Ashkenazu, A ^b   Espevik, T ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; LIGAND; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ARTICLE; CYTOTOXICITY; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET CELL;

ANTIGENS, CD95; APOPTOSIS REGULATORY PROTEINS; CELL MEMBRANE; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTRACELLULAR FLUID; JURKAT CELLS; LIGANDS; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MONOCYTES; PHAGOCYTOSIS; RNA, MESSENGER; SOLUBILITY; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034061453     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00671.x     Document Type: Article

References (27)

1. Gruss HJ, Dower SK. Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphomas. Blood 1995;85:3378-404.
2. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996;22:12687-90.
3. Wiley SR, Schooley K, Smolak PJ et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995;6:673-82.
4. Thomas WD, Hersey P. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells. J Immunol 1998; 5:2195-200.
5. Johnsen A-C, Haux J, Steinkjer B et al. Regulation of Apo-2 ligand/ TRAIL expression in NK cells - Involvement in NK cell mediated cytotoxicity. Cytokine 1999;11:664-72.
6. Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B. Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med 1998;12:2375-80.
7. Griffith TS, Wiley SR, Kubin MZ, Sedger LM, Maliszewski CR, Fanger NA. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J Exp Med 1999;8:1343-54.
8. Mariani SM, Krammer PH. Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells. Eur J Immunol 1998; 5:1492-8.
9. Jeremias I, Herr I, Boehler T, Debatin KM. TRAIL/Apo-2-ligand-induced apoptosis in human T cells. Eur J Immunol 1998;1:143-52.
10. Martinez-Lorenzo MJ, Alava MA, Gamen S et al. Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur J Immunol 1998;9:2714-25.
11. Mariani SM, Krammer PH. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage. Eur J Immunol 1998;3:973-82.
12. Snell V, Clodi K, Zhao SR et al. Activity of TNF-related apoptosisinducing ligand (TRAIL) in haematological malignancies. Br J Haematol 1997;3:618-24.
13. Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol 1998;6:2833-40.
14. Rieger J, Naumann U, Glaser T, Ashkenazi A, Weller M. APO2 ligand: A novel lethal weapon against malignant glioma? FEBS Lett 1998;1:124-8.
15. Kothny-Wilkes G, Kulms D, Poppelmann B, Luger TA, Kubin M, Schwarz T. Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand. J Biol Chem 1998;44:29247-53.
16. Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998;281:1305-8.
17. Alderson MR, Armitage RJ, Maraskovsky E et al. Fas transduces activation signals in normal human T lymphocytes. J Exp Med 1993;6:2231-5.
18. Bøyum AM. Separation of monocytes and lymphocytes. Scand J Immunol 1976;Suppl 5:9-15.
19. Kiener PA, Davis PM, Rankin BM et al. Human monocytic cells contain high levels of intracellular Fas ligand: Rapid release following cellular activation. J Immunol 1997;159:1594-8.
20. Medvedev AE, Johnsen A-C, Haux J et al. Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity. Cytokine 1997;9:394-404.
21. Rouvier E, Luciani MF, Golstein P. Fas involvement in Ca (2+)-independent T cell-mediated cytotoxicity. J Exp Med 1993;177:195-200.
22. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986;1:99-105.
23. Hofsli E, Bakke O, Nonstad U, Espevik T. A flow cytometric and immunofluorescence microscopic study of tumor necrosis factor production and localization in human monocytes. Cell Immunol 1989;122:405-15.
24. Munn DH, Cheung NK. Antibody-independent phagocytosis of tumor cells by human monocyte-derived macrophages cultured in recombinant macrophage colony-stimulating factor. Cancer ImmuNol Immunother 1995;1:46-52.
25. Savill J. Recognition and phagocytosis of cells undergoing apoptosis. Br Med Bull 1997;53:491-508.
26. Bonta IL, Ben-Efraim S. Involvement of inflammatory mediators in macrophage antitumor activity. J Leukoc Biol 1993;54:613-26.
27. Nissen-Meyer J, Hofsli E, Espevik T, Austgulen R. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes. Nat Immun Cell Growth Regul 1988;7:266-79.